VIZIENT, INC. for VIZIENT INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Inpatient Payment Rule - Advocated for legislation that would prevent the full extent of cuts to Medicare hospital inpatient payments that were included in the final CMS rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GOODMAN | — |
| CIDETTE PERRIN | — |
| STEVEN RIXEN | — |
Taxation/Internal Revenue Code TAX
Not-for-profit Hospital tax exemption - Tracked new requirements included in the Patient Protection and Affordable Care Act for not-for-profit hospitals to maintain tax exemption. Supported allowing hospitals to do consolidated reporting of community benefit on the Form 990 Schedule H.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GOODMAN | — |
| CIDETTE PERRIN | — |
| STEVEN RIXEN | — |
Health Issues HCR
Health Care Reform - monitored the regulatory activities surrounding the implementation of the Patient Protection and Affordable Care Act, particularly the legislative responses to the development of Accountable Care Organizations and a Value-based Purchasing system. Hospital Group Purchasing - Outreach and education efforts aimed at demonstrating the value GPOs provide to hospitals. Hospital Group Purchasing (Cont.) - worked to demonstrate the transparency of the GPO business model and value provided to hospitals in response to the Senate Finance Committee minority staff report on the industry. Health Care Information Technology - tracked the release of the regulations that determined if hospitals would be considered "meaningful users" of health IT. Advocated for legislation ( H.R. 6072, S. 3708) that would address an issue in the meaningful use regulation related to hospitals and health systems operating in multi-campus settings. Unique Device Identification - Advocated for the FDA to issue regulations to create a unique device identification system for medical devices, as required under the Food and Drug Amendments Act of 2006. H.R. 5820 - Monitored legislative efforts related to the Toxic Substances Control Act and analyzed potential impact on hospitals. Demonstrated VHA's tools for helping hospitals improve their clinical performance and prepare for the implementation of a Medicare value-based purchasing system. 340B (of the Public Health Services Act) drug pricing program - advocated for the inclusion of language in H.R. 4213 related to sharing of non-pricing information related to drugs in the 340B-1 program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GOODMAN | — |
| CIDETTE PERRIN | — |
| STEVEN RIXEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.